Cipla 2011

Posted: 1 Mar 2012

See all articles by Rohit Deshpande

Rohit Deshpande

Harvard Business School - Marketing Unit

Sandra J. Sucher

Harvard Business School

Laura Winig

Harvard Business School, Global Research Group

Date Written: April 12, 2011

Abstract

Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.

Learning Objective: Examine how a leader's moral commitments inform and shape the strategic decisions he takes.

Suggested Citation

Deshpande, Rohit and Sucher, Sandra J. and Winig, Laura, Cipla 2011 (April 12, 2011). Harvard Business School Marketing Unit Case No. 511-050. Available at SSRN: https://ssrn.com/abstract=2013232

Rohit Deshpande (Contact Author)

Harvard Business School - Marketing Unit ( email )

Soldiers Field
Boston, MA 02163
United States
617-495-5449 (Phone)
617-496-5853 (Fax)

Sandra J. Sucher

Harvard Business School ( email )

Soldiers Field Road
Morgan 479
Boston, MA 02163
United States

Laura Winig

Harvard Business School, Global Research Group ( email )

Greenhill House
Soldiers Field
Boston, MA 02163
United States

Register to save articles to
your library

Register

Paper statistics

Abstract Views
1,081
PlumX